CMC today announced that it has reached an agreement to buy the ICOS biologics operation from Eli Lilly and Company (NYSE: LLY).04-Dec-2007COPENHAGEN, Denmark, 4th December 2007CMC Biopharmaceuticals A/S (CMC) today announced that it has reached an agreement to buy the ICOS biologics development and manufacturing operation from Eli Lilly and Company (NYSE: LLY).The... CMC and Morphotek Inc. sign development and clinical supply agreement for therapeutic antibody to treat melanoma.01-Jun-2007COPENHAGEN, Denmark, June 1st, 2007CMC Biopharmaceuticals A/S (CMC), a leading provider of contract bio-manufacturing services to the biopharmaceutical industry, announced today it has entered into an agreement with Morphotek... Stallergenes and CMC sign manufacturing agreement for recombinant Bet v 114-May-2007Antony, France; Copenhagen, Denmark (May 14, 2007) – STALLERGENES SA and CMC Biopharmaceuticals A/S announce today that they have entered into an agreement for development and supply of recombinant Bet v 1 (rBet v 1) purified... CMC Biopharmaceuticals and Biotest Announce Manufacturing Agreement for BT-062 Antibody05-Feb-2007Copenhagen, Denmark; February 5 2007 – CMC Biopharmaceuticals A/S, a Copenhagen based contract manufacturing organization, and Biotest AG a developer of pharmaceutical, biotherapeutic and diagnostic products based in Dreieich,... CMC and Spine Wave announces manufacturing agreement for NuCore18-Aug-2006CMC Biopharmaceuticals A/S, a Copenhagen based contract manufacturing organization, and Spine Wave , Inc. a developer of advanced materials, techniques, and implant systems for spine surgery based in Shelton, CT announced today... Displaying results 6 to 10 out of 10 |  | ||||